DDD-107498
- Generic Name
- DDD-107498
First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Participants
- First Posted Date
- 2017-08-25
- Last Posted Date
- 2023-10-16
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 88
- Registration Number
- NCT03261401
- Locations
- 🇦🇺
Q-Pharm Pty Ltd, Brisbane, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath